Uploaded August 2026 | Updated September 2026, 1 week ago
A swiftly approved new drug is alleged to nearly double a patient's survival time with pancreatic cancer. (Via CBS).
A swiftly approved new drug is alleged to nearly double a patient's survival time with pancreatic cancer. (Via CBS).










